(MedPage Today) — Prediction markets operator Kalshi recently announced that it will permit customers to bet on whether late-stage clinical trials will reach their primary endpoints. While Kalshi has stated this will be a limited roll-out, with…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
